Defibrillator Market to Reach USD 25.97 Billion by 2033, Growing at 7.18% CAGR | Straits Research

According to a new report by Straits Research, the global defibrillator market size, valued at USD 13.91 billion in 2024, is projected to grow from USD 12.11 billion in 2025 to USD 25.97 billion by 2033, expanding at a compound annual growth rate (CAGR) of 7.18% during the forecast period (2025-2033).

A defibrillator is a life-saving medical device used to deliver a therapeutic electric shock to the heart to restore normal rhythm in cases of cardiac arrhythmia, ventricular fibrillation, or sudden cardiac arrest (SCA). These devices available as manual, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs) are essential in emergency care to depolarize heart muscles and reestablish proper cardiac function.

Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart) : https://straitsresearch.com/report/defibrillator-market/request-sample

Rising Prevalence of Cardiac Diseases Fueling Market Expansion

The global rise in cardiovascular disorders is a primary factor driving the demand for defibrillators. Increasing stress, sedentary lifestyles, tobacco and alcohol consumption, and substance abuse have contributed to a surge in heart-related conditions across age groups. According to the International Journal of Stroke (2020), the global prevalence of atrial fibrillation reached 37.57 million cases representing a 33% increase over the past two decades and is projected to rise by over 60% by 2050. This increasing burden of arrhythmia and cardiac disease is expected to significantly boost market growth.

Growing Geriatric Population and Public Access AED Installations

The growing elderly population, which is more susceptible to cardiovascular ailments, is another critical market driver. As per the United Nations Department of Economic and Social Affairs, the global population aged 65 and older is projected to double from 727 million in 2020 to 1.5 billion by 2050, increasing the prevalence of chronic diseases such as cardiovascular disorders.

At the same time, the installation of Automated External Defibrillators (AEDs) in public spaces such as schools, airports, malls, and train stations is becoming more widespread due to increased awareness of their life-saving capabilities. Many governments are implementing initiatives to promote Public Access Defibrillators (PADs) to enhance emergency response to sudden cardiac arrests, further boosting the market outlook.

Technical and Cybersecurity Challenges May Impede Growth

Despite promising growth prospects, technical failures and cybersecurity risks pose notable challenges to market expansion. Device malfunctions related to battery, software, or hardware can hinder performance and potentially lead to patient harm. Several defibrillator recalls in recent years have resulted from issues such as improper shock delivery or electrical faults.

Additionally, concerns regarding the cybersecurity of implantable defibrillators have emerged. In 2019, the FDA raised issues regarding the lack of encryption in wireless telemetry equipment used by certain manufacturers, including Medtronic, underscoring the need for improved data protection in connected medical devices.

For more insights and detailed analysis on the Market, visit : https://straitsresearch.com/report/defibrillator-market

Market Opportunities: Advancements in Next-Generation Defibrillators

The industry is witnessing significant innovation with the introduction of next-generation and MRI-compatible defibrillators, creating new opportunities for market players. The development of Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) and MRI-compatible ICDs and CRT-Ds is expected to enhance patient safety and expand the adoption of defibrillation technologies.

The increasing use of Automated External Defibrillators (AEDs) among heart failure patients and the growing availability of wearable external defibrillators will continue to strengthen market potential in the coming years.

Regional Insights

North America dominated the global market in 2021, accounting for over 40% of total revenue, supported by advanced healthcare infrastructure, favorable regulations, and the strong presence of key players. The Centers for Disease Control and Prevention (CDC) reported that around 659,000 Americans die annually from heart disease, with over 805,000 experiencing heart attacks conditions that continue to fuel regional demand for defibrillation devices.

Asia Pacific (APAC) is expected to register the fastest growth rate (CAGR 7.88%) during the forecast period, driven by rising cardiovascular disease prevalence, growing healthcare investment, and increased adoption of AEDs in public areas. Japan, led by companies such as Nihon Kohden Corporation, remains a key contributor to regional expansion.

Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart) : https://straitsresearch.com/report/defibrillator-market/request-sample

Market Segmentation Overview

By Product:

Implantable Cardioverter Defibrillators (ICDs)
External Defibrillators (EDs)

ICDs accounted for over 72% of market share in 2021 due to their high adoption in cardiac treatment. The external defibrillator segment is projected to grow at a CAGR of 9.29%, supported by technological advancements and favorable government policies promoting AED accessibility.

By End User:

Hospitals
Pre-Hospital
Public Access Market
Alternate Care Market
Home Healthcare

Hospitals represented over 75% of total revenue in 2021, driven by increased cardiac procedures and the widespread adoption of both implantable and external defibrillators. Meanwhile, the Public Access Market is expected to grow the fastest (CAGR 9.58%), propelled by community-level initiatives to install AEDs in public places and train responders.

Key Market Players

Stryker Corporation
Asahi Kasei Corporation
Abbott
BIOTRONIK SE & Co. KG
Medtronic plc
Cardiac Science Corporation
Boston Scientific Corporation
Philips Healthcare
LivaNova PLC
Nihon Kohden Corporation
Jude Medical, Inc.
MicroPort Scientific Corporation
Koninklijke Philips N.V.
Schiller AG

Browse More Insights & Reports

Active Implantable Medical Devices Market : https://straitsresearch.com/report/active-implantable-medical-devices-market

Automated External Defibrillators Market : https://straitsresearch.com/report/automated-external-defibrillators-market

Bioelectric Medicine Market : https://straitsresearch.com/report/bioelectric-medicine-market

Brugada Syndrome Market : https://straitsresearch.com/report/brugada-syndrome-market

Cardiac Resynchronization Therapy (CRT) Market : https://straitsresearch.com/report/cardiac-resynchronization-therapy-market

Contact Us

Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.

+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

About Us

For over a decade, Straits Research has been a trusted partner to more than 2,000 small and large enterprises, empowering senior leaders and decision-makers with actionable intelligence to navigate complex markets. Our structured syndicate reports, published year-round, cover critical sectors such as chemicals, materials, food and beverage, healthcare, pharmaceuticals, automotive, technology, aerospace, and defense. Combined with our custom research tailored to client-specific needs, we deliver insights that drive business progress and informed decision-making.

This release was published on openPR.